Querol, Luis http://orcid.org/0000-0002-4289-8264
Crabtree, M. http://orcid.org/0000-0001-5310-6595
Herepath, M.
Priedane, E. http://orcid.org/0000-0003-3600-1569
Viejo Viejo, I.
Agush, S.
Sommerer, P.
Funding for this research was provided by:
CSL Behring
Article History
Received: 19 March 2020
Revised: 10 June 2020
Accepted: 12 June 2020
First Online: 24 June 2020
Compliance with ethical standards
:
: No primary research was performed as part of this study.
: LQ has provided expert testimony for Grifols, Sanofi-Genzyme, Novartis, UCB, Roche, and CSL Behring, and received research funds from Novartis Spain, Sanofi-Genzyme, and Grifols. MC, EP, and SA are, or were, employees of Huron Consulting Group. Huron Consulting Group received funding from CSL Behring GmbH to perform the study. IV and PS are, or were, employees of CSL Behring GmbH. MH is an employee of Optimal Access Life Science Consulting Limited and received funding from CSL Behring.